Hiroyuki Nakamura; Kazutetsu Aoshiba Idiopathic Pulmonary Fibrosis 9784431562818

Варианты приобретения

Цена: 12577.00р.
Кол-во:
Наличие: Поставка под заказ. Есть в наличии на складе поставщика.
Склад Америка: Есть
При оформлении заказа до: 2025-09-15
Ориентировочная дата поставки: Октябрь
При условии наличия книги у поставщика.

Добавить в корзину

в Мои желания

Автор: Hiroyuki Nakamura; Kazutetsu Aoshiba
Название: Idiopathic Pulmonary Fibrosis
ISBN: 9784431562818
Издательство: Springer
Классификация:

Лечение респираторных заболеваний

Клеточная биология (цитология)

ISBN-10: 4431562818
Обложка/Формат: Paperback
Страницы: 259
Вес: 0.42 кг.
Дата издания: 23.08.2016
Язык: English
Издание: Softcover reprint of
Иллюстрации: 19 tables, black and white; x, 259 p.; 19 tables, black and white; x, 259 p.
Размер: 234 x 156 x 15
Читательская аудитория: General (us: trade)
Основная тема: Medicine & Public Health
Подзаголовок: Advances in Diagnostic Tools and Disease Management
Ссылка на Издательство: Link
Рейтинг:
Поставляется из: Германии
Описание: From epidemiology and pathogenesis to disease management, this book reviews our current understanding of and provides up-to-date information of Idiopathic Pulmonary Fibrosis (IPF). A subtype of Idiopathic Interstitial Pneumonias (IIP), IPF is one of the most elusive and intractable respiratory disease to date and its triggering factors remain unclear. However, new developments such as serum markers that are highly specific to IPF (i.e. KL-6, SP-A, and SP-D), the establishment of systematic diagnostic imaging (HRCT) and accumulated reports of treatment using an antifibrotic agent (pirfenidone) are slowly improving our understanding of the disease. Edited by an established authority in the field and written by experts, this book will be valuable to not only to beginning learners but also to physicians, instructors and researchers whose work involves IIPs. With each chapter exploring critical questions, with unresolved issues and future prospects, the book offers a valuable resource for understanding issues such as the newly proposed entity of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema: CPFE) and the mechanism of how so many IIP sufferers develop lung cancer.
Дополнительное описание: Part 1.- Definition, epidemiology, and pathogenesis .- Chapter 1: Definition of IPF (Question: Is the latest classification [ATS/ERS] satisfactory?).- Chapter 2: Epidemiology and risk factors of IPF (Question: Can we dare to ask, “What are the possible ca

Idiopathic Pulmonary Fibrosis, Hiroyuki Nakamura; Kazutetsu Aoshiba